Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 15;207(10):1266-1268.
doi: 10.1164/rccm.202302-0326ED.

The Cellular Landscape of Chronic Thromboembolic Pulmonary Hypertension Revealed by Single-Cell Sequencing: Therapeutic Implications?

Rozenn Quarck  1 , Harm Jan Bogaard  2 , Marion Delcroix  3
Affiliations
Editorial

The Cellular Landscape of Chronic Thromboembolic Pulmonary Hypertension Revealed by Single-Cell Sequencing: Therapeutic Implications?

Rozenn Quarck et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Therapeutic implications. Emergence of in vitro microfluidic devices, reliable and suitable animal models, and cell atlas will contribute to identifying novel therapeutic targets to treat patients at risk of developing CTEPH (1) after acute PE, versus (2) inoperable patients, or (3) patients with residual or recurrent PH after PEA or BPA. BPA = balloon pulmonary angioplasty; CTEPH = chronic thromboembolic pulmonary hypertension; PE = pulmonary embolism; PEA = pulmonary endarterectomy; PH = pulmonary hypertension.
See this image and copyright information in PMC

Comment on

References

    1. Delcroix M, Torbicki A, Gopalan D, Sitbon O, Klok FA, Lang I, et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J . 2021;57:2002828. - PubMed
    1. Dorfmüller P, Günther S, Ghigna MR, Thomas de Montpréville V, Boulate D, Paul JF, et al. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J . 2014;44:1275–1288. - PubMed
    1. Viswanathan G, Kirshner HF, Nazo N, Ali S, Ganapathi A, Cumming I, et al. Single-cell analysis reveals distinct immune and smooth muscle cell populations that contribute to chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med . 2023;207:1358–1375. - PMC - PubMed
    1. Quarck R, Wynants M, Verbeken E, Meyns B, Delcroix M. Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension. Eur Respir J . 2015;46:431–443. - PubMed
    1. Bernard J, Yi ES. Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution. Hum Pathol . 2007;38:871–877. - PubMed

MeSH terms